BIOTECHS : bursting the bubble
​Biotechs have led the Nasdaq and the S&P 500 rally since 2008. This has just changed. They are now, and for the first time, leading the fall. They have also been through the typical bubble pattern. That bubble is going through the first stage of the burst. There should be an opportunity to sell at better prices than today next year, but Biotechs have topped for several years.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.